Substituted isochroman compounds for the treatment of metabolic disorders, cancer and other diseases

Details for Australian Patent Application No. 2004232326 (hide)

Owner Incyte Corporation Ortho-McNeil Pharmaceutical Inc.

Inventors Al-Shamma, Hussien A.; Chen, Qing; Guo, Jianhua; Tachdjian, Catherine; Giachino, Andrea Fanjul; Zapf, James W.; Boudjelal, Mohamed; JakubowiczJaillardon, Karine; Pfahl, Magnus

Agent Griffith Hack

Pub. Number AU-A-2004232326

PCT Pub. Number WO2004/093809

Priority 60/464,388 18.04.03 US

Filing date 19 April 2004

Wipo publication date 4 November 2004

International Classifications

C07D 277/04 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 031/42 - Oxazoles

Event Publications

1 December 2005 PCT application entered the National Phase

  PCT publication WO2004/093809 Priority application(s): WO2004/093809

3 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232328-Methods and compositions for treating disorders

2004232317-Bone plate stabilization system and method for its use